Compounds acting as melanocortin receptor ligands
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 26, 2006
Grant Date -
Jan 29, 2004
app pub date -
Aug 7, 2001
filing date -
Aug 7, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides novel compounds and use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: Wherein X and Y are independently chosen from O, N, S and (CH.sub.2).sub.n, where n is 0, 1, 2, 3, 4, or 5, or a combination of these and may contain carbon-carbon multiple bonds and branched chains as well as alicyclic and heterocyclic groups; Q is H or OH; R.sub.1 and R.sub.2 can be either the same or different and are chosen from hydrogen or the residue of an aromatic group as listed in Scheme 1 and the pharmacologically active salts thereof ##STR00001##
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully